Biomedical Informatics

Working in healthcare or life sciences and want to meaningfully apply LLMs? While generic LLM courses/materials abound, deploying models in regulated, high-stakes environments like drug discovery, real-world evidence, or clinical decision support demands more than technical fluency — it requires a deep understanding of biomedical data, clinical workflows, and regulatory frameworks. 👇 Below is a structured path, curated for professionals advancing AI in healthcare and the life sciences, with resources that matter in our context. 📍 Step 1: Core ML/LLM Concepts With Biomedical Applications -Stanford's AI in Healthcare Specialization on Coursera: Focuses on real-world ML applications in medicine -MIT xPro Online: AI in Healthcare Program — includes clinical datasets & lectures 📍 Step 2: Biomedical NLP & Domain-Specific Transformers 👉 Understand how foundational models adapt to clinical and biomedical text: -BioNLP Specialization – Coursera/DeepLearning.AI -BioGPT: Microsoft’s biomedical LLM -ClinicalBERT: Pre-training clinical notes on EHRs -Med-PaLM: LLMs aligned with medical expert benchmarks -GatorTron: Massive clinical transformer -ScispaCy – biomedical named entity recognition 📍 Step 3: Familiarize Yourself with Retrieval-Augmented Generation (RAG) in Scientific & Clinical Domains 👉 RAG is essential when grounding outputs in validated, evolving evidence: -Galactica by Meta – trained on scientific literature -BioMedLM – fine-tuned on medical publications 📍 Step 4: Agents in Clinical Workflows & Biomedical Research 👉 Multi-agent systems have emerging relevance in diagnostics, evidence curation, and trial automation. Familiarize yourself with these tools: -LangChain + LangGraph -CrewAI: Build research assistants #HealthcareAI #BioNLP #LLM #MedTech #DigitalHealth #RAG #BiomedicalAI #PrecisionMedicine #ClinicalAI #AIinPharma #LLMstrategy #HealthEquity #RealWorldEvidence

Heterogeneous datasets are pervasive today, existing in various domains. Objects within these complex datasets are often represented from different perspectives, at different scales, or through multiple modalities, such as images, sensor readings, language sequences, and compact mathematical statements. Such datasets have been analyzed in the past using Multi-View Learning (MVL), Multi-Task Learning (MTL), and Tensor Learning (TL). In recent years, Multi-Modal Learning (MML) has also been employed. MML is a Machine Learning (ML) approach that integrates and processes information from multiple types of data, with different "perspectives" or "modalities" such as text, images, audio, video, or sensor data. The goal of MML is to leverage the complementary strengths of these modalities to improve model performance and enable richer understanding and predictions. Precision medicine and personalized clinical decision support systems (CDSS) tools have long aimed to leverage multimodal patient data to better capture complex, high-dimensional patient states and provider responses. This data ranges from free-form text notes and semi-structured electronic health records (EHR) to high-frequency physiological signals. While the advent of transformer architectures has enabled deeper insights from merging modalities, it has also required meticulous feature engineering and alignment. In patient monitoring, effectively analyzing diverse physiological signals within CDSS is highly challenging. #MedicalInformatics To address the challenges of analyzing multimodal patient data, the authors of [1] introduce MedTsLLM, a general multimodal large language model (LLM) framework that effectively integrates time series data and rich contextual information in the form of text. This framework performs three clinically relevant tasks (in time-series) which enable deeper analysis of physiological signals and can provide actionable insights for clinicians: • semantic segmentation • boundary detection • anomaly detection At a high level, boundary detection splits signals into periods like breaths or beats. Semantic segmentation further splits time series into distinct, meaningful segments. Anomaly detection identifies periods within the signals that deviate from normal. MedTsLLM utilizes a reprogramming layer to align embeddings of time series patches with a pretrained LLM's embedding space, making effective use of raw time series in conjunction with textual context. They additionally tailored the text prompt to include patient-specific information. Their experiments showed that MedTsLLM outperforms state-of-the-art baselines, including deep learning models, other LLMs, and clinical methods, across multiple medical domains, specifically electrocardiograms (ECG) and respiratory waveforms. Links to their preprint [1] and #Python GitHub repository [2] are shared in the comments.

Are biomedical AI models truly as smart as they seem? 🧠 ✨ Our new paper in Nature Machine Intelligence introduces SPECTRA, a framework that evaluates models by considering the full spectrum of cross-split overlap: train-test similarity Paper: https://rdcu.be/d2D0z Code: https://lnkd.in/ef__Xg5B SPECTRA reveals gaps in benchmarks for molecular sequence data across 19 models, including LLMs, GNNs, diffusion models, and conv nets, and 18 molecular sequencing datasets, showing that as cross-split overlap decreases, model performance consistently declines, varying by task and model Yasha Ektefaie, Andrew Shen, Daria Bykova, Maximillian G. Marin, Maha Farhat Harvard Medical School Department of Biomedical Informatics Kempner Institute at Harvard University Harvard Data Science Initiative Broad Institute of MIT and Harvard

Not every shiny ML algorithm belongs in Bioinformatics. Bioinformatics doesn’t just need AI. It needs Bio-aware AI. In the rush to apply the latest AI/ML models to every problem, there’s a reality check many overlook: 👉 Bioinformatics ≠ generic tabular data. 👉 Bioinformatics ≠ simple image recognition. 👉 Bioinformatics ≠ “just another dataset.” Genomics, proteomics, structural biology, and systems biology produce data with unique statistical distributions, noise profiles, and biological constraints. - Sequence data isn’t like stock market data. - Protein structures don’t behave like social network graphs. - Gene expression matrices are not regular spreadsheets. This is why some ML models that dominate in other fields (finance, NLP, recommender systems) break down in bioinformatics unless carefully adapted. In Bioinformatics, success comes when: Algorithms are tuned for biological priors. Models respect the physics & chemistry of life. Data preprocessing mirrors the complexity of biology, not just math. The best ML algorithm is not the “newest” one, it’s the one that truly understands biological data. Here are the top ML/LLM models in 2025: - AlphaGenome (June 2025): Gene regulation & variant impact from long DNA sequences - AlphaFold 3 (Launched 2024; widely adopted by 2025): Protein complex, ligand, DNA/RNA structure prediction - SonicParanoid2 (2024): Fast orthologous gene inference using ML & LMs - NuFold (2025): RNA 3D prediction using AlphaFold 2 architecture - trRosettaRNA (Recent): Transformer-based RNA tertiary structure modeling - esmGFP / ESM3-derived protein design (Published Jan 2025): AI-designed protein simulating evolutionary processes - Generative AI Models: DNABERT, DNAGPT, GENA LM: DNA sequence modeling and classification with LLMs - EMitool (2025): Explainable multi-omics integration for cancer subtyping - DeepGO-SE and TAWFN (2025): Enhanced protein function inference via embeddings and GNNs - Graph Neural Networks (GNNs) (Growing relevance by 2025): Modeling biological networks and spatial gene expression - Quantum-Inspired Algorithms: QSVM, QNN, VQE, QFT: Experimental bioinformatics acceleration via quantum algorithms - BioMaster (2025): Automated bioinformatics pipeline management with LLM agents Models like AlphaGenome or DeepGO-SE are purpose built for biology they understand sequence context, structure, or biological ontologies. AlphaGenome handles million-base pair sequences; ESM3 was trained on hundreds of billions of protein. NuFold, AlphaFold 3, and trRosettaRNA capture 3D structure; GNNs model networks and tissue spatial contexts. Tools like EMitool and BioMaster support interpretability and autonomous workflows. Quantum-inspired algorithms and LLM agents (e.g., BioMaster) point toward the next wave of bioinformatics automation and acceleration.

You didn’t pursue a career in healthcare informatics just to chase outdated job titles. The world is changing. So are the roles. If you're still searching with 2015 job titles, you’ll miss the 2030 opportunities. Here’s the truth: The next decade will belong to those who understand not just healthcare, but data, automation, and digital systems together. And Healthcare Informatics is at that intersection. Top Hiring Trends for Healthcare Informatics (2024–2025): According to [HIMSS & BLS 2024 projections]: Healthcare Data Analyst roles grew by 18% last year. Clinical Decision Support & AI roles are emerging in major health systems. EHR System Support & Optimization remains the most in-demand skill. Population Health & Value-Based Care roles up by 11% due to Medicaid reforms. Clinical Research Informatics is growing in pharma/biotech. 2025–2035: What Roles Will Dominate? If you’re planning for long-term success, focus on roles that blend: Data + Outcomes AI + Patient Safety Compliance + Digital Health Here are the future-proof titles to track (and skill up for): Next-Gen Healthcare Informatics Roles: Healthcare Data Scientist (Python, SQL, predictive analytics) Clinical AI Analyst (ML models for outcomes + risk prediction) Digital Health Program Manager (mHealth, RPM, app-based care) Value-Based Care Analyst (Population health metrics, QI dashboards) Health Data Governance Specialist (HIPAA, HITECH, compliance) Clinical Informatics Consultant (Epic/Cerner + workflow redesign) Health Equity Data Analyst (DEI metrics, SDoH data) Telehealth Informatics Coordinator (virtual care workflows + UX design) Top Skills to Focus on (2025 and beyond): SQL, Python/R for health data Power BI / Tableau for dashboarding Epic or Cerner EHR optimization Clinical workflow mapping & UI/UX HL7, FHIR, interoperability knowledge Privacy regulations (HIPAA, GDPR) AI/ML foundations for clinical contexts Job Hunting Tip: Don’t search by degree. Search by outcome. Try: “Remote Patient Monitoring + Analyst” | “Epic + Optimization” | “Public Health + Data” These combos will open new doors. Tag a classmate, I’ll help you decode job titles, keywords, and roles that actually work in 2025. We rise faster when we learn together 💙 #HealthInformatics #HealthcareAnalytics #PublicHealthCareers #EntryLevelJobs #InternationalStudent #HealthTech

Skills Bioinformatics Needs to be Future Proof Everyone’s talking about AI transforming bioinformatics. But while you are learning the latest ML frameworks, two quieter trends are fundamentally reshaping what it means to be a computational biologist. Data Engineering is Bleeding Into Biology The bioinformatics field is adopting enterprise data practices. Data lineage tracking, automated testing, CI/CD pipelines are no longer just buzzwords anymore, they are becoming core competencies. Modern job postings routinely ask for containerisation, workflow orchestration, and cloud-native thinking alongside traditional genomics skills. Why? Because as datasets scale and analyses become more complex, the infrastructure matters as much as the algorithms. Teams that master data engineering principles are building sustainable competitive advantages while others debug pipeline failures. Reproducible Analytics Isn’t Optional Anymore The five pillars of computational reproducibility (literate programming, version control, environment control, persistent data sharing, and documentation) are evolving from best practices to basic requirements. This is all about operational efficiency. When your analysis can be reliably reproduced six months later, you are not rebuilding from scratch you are building incrementally. The Skills Convergence So my conviction is that the most valuable bioinformaticians in the coming years won’t just understand biology and statistics. They will think like data engineers who happen to specialize in genomics. They will build systems that are reproducible-by-design, scalable-by-default, and maintainable-by-others. What This Means for Your Career While everyone rushes toward AI specialization, consider investing time in foundations such as: - Workflow managers (Nextflow, Snakemake) - Containerization and environment management - Data versioning and lineage tracking - Infrastructure-as-code thinking - Collaborative development practices Industry is well along this transition where we can see the teams best positioned for AI integration are those with solid data engineering foundations. You can’t build reliable AI-powered analyses on unreliable infrastructure. The future belongs to bioinformaticians who combine biological insight with engineering discipline. This builds a strong foundation to leverage emerging AI tools, rather than just following the latest AI trends. #Bioinformatics #DataEngineering #ReproducibleResearch #ComputationalBiology #CareerDevelopment #BioinformaticsSkills

Researchers have been duct taping biology workflows together for decades. SciSpace just flipped the script. They built a BioMed Agent that takes you from idea to interpretation in a single reasoning chain. Not a chatbot. Not a toy. A system that thinks like a biological scientist. Modern biology is chaos. You search papers. Design constructs. Run omics. Analyze variants. Draft figures. All in different tools. All manually stitched. BioMed Agent pulls this into one unified intelligence. It is not a general assistant. It is a domain-built engine trained for molecular, cellular, and clinical reasoning. You ask biological questions. It responds with workflows, not text blurbs. I tried it on a cloning problem. One prompt defined the strategy, vector backbone, restriction sites, primers, and QC checks. It even flagged conflicts in the design automatically. That is real experimental planning, not autocomplete. Then I switched to immune profiling. I dropped in bulk RNA-seq from activated T cells. It processed counts, normalized data, ran differential expression, and surfaced pathway enrichments. A full analysis cycle in minutes, not days. Genomics is where it really shows depth. Feed it a variant list and phenotype notes. It prioritizes candidates, reads ClinVar logic, checks inheritance patterns, and scores pathogenicity. This is built for real cases, not conference demos. It also runs drug logic. You can compare inhibitors, predict ADMET liabilities, map pathway effects, and surface off-target risks in a single flow. It feels like the scaffolding of an integrated discovery engine. And then there is the illustration layer. Describe a mechanism, a signaling axis, or a clinical workflow. The agent creates clear, publication-grade diagrams that match your scientific intent. Need revisions? Remove a component. Add a molecular event. Change directionality. The system redraws the entire figure around your biological instructions. A design tool built on scientific logic, not clip art. For labs, clinics, and biotech teams, this unlocks something new: Experiment design, computational analysis, variant interpretation, and figure creation finally live in one place. It compresses timelines at every stage of discovery. If you want to feel what an integrated scientific agent actually is, here is early access: Try BioMed Agent → https://lnkd.in/gbtTHuGn Global: PPBIO20 (20% off monthly), PPBIO40 (40% off annual). India: PPBIO30 (30% off monthly & annual on Premium/Advanced). Give it your hardest prompt. Watch how it builds the reasoning chain you used to assemble by hand.

Democratizing Biomarker Discovery: omicML Bridges Transcriptomics and Machine Learning Biomarker discovery has long been a technical bottleneck, fragmented across pipelines, programming languages, and statistical tools that demand both coding expertise and computational intuition. A new study describes the omicML framework and attempts to change that paradigm. OmicML integrates bioinformatics and machine learning into a unified, no-code platform for transcriptomic biomarker identification. It enables seamless workflows, from data upload and quality control to differential expression, feature selection, and predictive model generation, through an intuitive graphical interface. Key innovation: omicML merges R and Python workflows under a single GUI, supporting both RNA-seq and microarray data, and automates ML-based feature selection, benchmarking, and validation using nested cross-validation. This empowers biologists to go from raw data to predictive biomarkers without writing a single line of code. Case study highlight: Using multi-platform datasets, the team applied omicML to identify biomarkers of monkeypox virus (MPXV) infection. ▪️ A six-gene diagnostic model, ZNF212, ZNF451, PLAGL1, NFAT5, ICAM5, and RRAD, achieved outstanding diagnostic accuracy (AUROC 0.95; AUPRC 0.92), distinguishing Mpox from SARS-CoV-2, HIV, Ebola, and varicella with remarkable specificity. ▪️ Among these, RRAD emerged as the top-performing single-gene biomarker, offering a potential new diagnostic anchor for viral infections. OmicML exemplifies an advance in translational bioinformatics, lowering the barrier for non-programmers, accelerating multi-omics integration, and providing a reproducible foundation for AI-driven precision medicine. By merging data science rigor with accessibility, it redefines how academic and clinical researchers can translate high-dimensional expression data into actionable diagnostic or therapeutic insights. As machine learning continues to reshape biomedical discovery, tools like omicML will be pivotal in expanding who can contribute to innovation, bridging the gap between bench scientists and computational biology. Website: https://omicml.org Read the preprint: https://lnkd.in/eUxe8yca #Bioinformatics #MachineLearning #Biomarkers #Transcriptomics #PrecisionMedicine

BioMCP powers biomedical agents with 9 article capabilities across PubMed, Semantic Scholar, Europe PMC, and PubTator3 — federated, deduplicated, one grammar: - Search by gene, disease, drug, author, keyword, date, article type — all combinable - Get article detail with abstract, DOI, citation count, open-access status - AI summaries (TLDRs) so the agent triages 20 papers in seconds - Forward citations with intent labels (why was this paper cited?) - Backward references to trace intellectual lineage - Content-based recommendations (similar papers by meaning, not keywords) - Entity extraction: every gene, drug, disease, and mutation auto-linked to runnable BioMCP commands - Full text retrieval from PubMed Central Open Access - Batch compare: side-by-side TLDRs, citation counts, and influence metrics for a shortlist 200 million papers. No API wrangling. The agent searches, reads, traverses citations, extracts entities, and jumps to the next query — all in structured output it can reason about. BioMCP is an open-source CLI and MCP server that federates 37 biomedical data sources across 12 entity types — genes, variants, trials, drugs, articles, diseases, pathways, proteins, adverse events, pharmacogenomics, GWAS, and phenotypes. One grammar queries all of them, and every result links to the next: a gene connects to its drugs, a drug to its trials, a trial to its variants, a variant back to the literature. The agent follows the chain without switching tools or learning new APIs. Full walkthrough of all 9 capabilities with real output: https://lnkd.in/gcKWuBK7 Documentation: https://biomcp.org Code: https://lnkd.in/ggkRREYS #agents #mcp #biomedical #biomcp

Proud to share that our review article on Recent Advances in AI and Generative AI for Health Informatics has just been published in Healthcare (MDPI ). In this paper, we synthesize the latest developments in AI, GenAI, and large language models within health informatics, with a focus on how these technologies are being applied to: • clinical decision support • electronic health records • patient care analytics • hospital management • remote patient monitoring We also highlight persistent structural challenges — including privacy, ethics, explainability, accountability, and workforce engagement — that must be addressed for these technologies to deliver sustained impact. Deep thanks to SIO IONG AO, our principal author, for his exceptional leadership, intellectual rigor, and collaboration throughout this work. Read the full paper here: https://lnkd.in/ghPJkqrH University of Waterloo Waterloo Regional Health Network (WRHN) Vasile Palade Christopher Holt, PhD SUZY ARAUJO Mike Gourlay, MBA, CPA, CMA Vivek Goel Ron Gagnon #AIinHealthcare #HealthInformatics #GenAI #DigitalHealth #ImplementationScience #HealthTech